|
|
|
|
| LEADER |
01000naa a22002652 4500 |
| 001 |
NLM074101137 |
| 003 |
DE-627 |
| 005 |
20231222021913.0 |
| 007 |
tu |
| 008 |
231222s1980 xx ||||| 00| ||eng c |
| 028 |
5 |
2 |
|a pubmed24n0247.xml
|
| 035 |
|
|
|a (DE-627)NLM074101137
|
| 035 |
|
|
|a (NLM)7433479
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 100 |
1 |
|
|a Barber, J H
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Intermittent claudication
|b a controlled study in parallel time of the short-term and long-term effects of cinnarizine
|
| 264 |
|
1 |
|c 1980
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 500 |
|
|
|a Date Completed 16.01.1981
|
| 500 |
|
|
|a Date Revised 21.11.2013
|
| 500 |
|
|
|a published: Print
|
| 500 |
|
|
|a Citation Status MEDLINE
|
| 520 |
|
|
|a In a group of 45 patients with mild to moderately severe claudication studied over the same 4-month period, cinnarizine administration (75 mg 3-times daily) was associated with a greater than 20% improvement in walking distance in 65% of the patients, who derived significantly more benefit than the 30% of placebo responders. The mean improvement in walking distance was 11% for the placebo group compared to 142% for cinnarizine-treated patients. An open 12-month follow-up showed that improvements in walking distance with cinnarizine were maintained in all 12 patients, whereas in the 10 control patients only 10% reported improvement. Objectively, significant plethysmographic improvements were detected only for the cinnarizine-treated patients and shown by an increase in arterial flow-pressure dynamics of the lower limbs
|
| 650 |
|
4 |
|a Clinical Trial
|
| 650 |
|
4 |
|a Journal Article
|
| 650 |
|
4 |
|a Randomized Controlled Trial
|
| 650 |
|
7 |
|a Piperazines
|2 NLM
|
| 650 |
|
7 |
|a Cinnarizine
|2 NLM
|
| 650 |
|
7 |
|a 3DI2E1X18L
|2 NLM
|
| 700 |
1 |
|
|a Reuter, C A
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Jageneau, A H
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Loots, W
|e verfasserin
|4 aut
|
| 773 |
0 |
8 |
|i Enthalten in
|t Interim guidelines for the control of infections with Vero cytotoxin producing Escherichia coli (VTEC). Subcommittee of the PHLS Working Group on Vero cytotoxin producing Escherichia coli (VTEC)
|d 1995
|g 2(1980), 6 vom: 08., Seite 401-7
|w (DE-627)NLM023961570
|
| 773 |
1 |
8 |
|g volume:2
|g year:1980
|g number:6
|g day:08
|g pages:401-7
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_11
|
| 912 |
|
|
|a GBV_ILN_22
|
| 912 |
|
|
|a GBV_ILN_24
|
| 912 |
|
|
|a GBV_ILN_31
|
| 912 |
|
|
|a GBV_ILN_39
|
| 912 |
|
|
|a GBV_ILN_40
|
| 912 |
|
|
|a GBV_ILN_72
|
| 912 |
|
|
|a GBV_ILN_120
|
| 912 |
|
|
|a GBV_ILN_121
|
| 912 |
|
|
|a GBV_ILN_350
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 2
|j 1980
|e 6
|b 08
|h 401-7
|